Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Immunotherapy with in vitro-selected antigen-specific lymphocytes after nonmyeloablative lymphodepleting chemotherapy

Immunotherapy with in vitro-selected antigen-specific lymphocytes after nonmyeloablative lymphodepleting chemotherapy

US Patent 8287857 · Granted Oct 16, 2012

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

T cell receptors recognizing R175H or Y220C mutation in P532025
Methods of conditioning patients for T cell therapy2025
HLA class II-restricted t cell receptors against RAS with G12R mutation2025
T cell receptors recognizing HLA-A1-restricted MAGE-A32025
T cell receptors recognizing MHC class II-restricted MAGE-A32025
Anti-KRAS-G12D T cell receptors2025
HLA class II-restricted t cell receptors against mutated RAS2025
Methods for selectively expanding cells expressing a TCR with a murine constant 2025
Methods of enriching cell populations for cancer-specific T cells using in vitro2025
Anti-human papillomavirus 16 E6 T cell receptors2025
Methods of isolating T cells having antigenic specificity for a cancer-specific 2024
Methods of preparing an isolated population of dendritic cells and methods of tr2024